Table 1 Correlation between the level of CHREBP and the pathological parameters of GC samples (n = 54).
From: CHREBP suppresses gastric cancer progression via the cyclin D1-Rb-E2F1 pathway
CHREBP expression level | |||||||
|---|---|---|---|---|---|---|---|
Parameters | Category | No. | Negative | Weakly positive | Strongly positive | χ2 | P-value |
Age at surgery (years old) | <60 | 15 | 5 | 8 | 2 | 0.494 | 0.781 |
≥60 | 39 | 17 | 18 | 4 | |||
Sex | Male | 38 | 16 | 18 | 4 | 0.114 | 0.944 |
Female | 16 | 6 | 8 | 2 | |||
T stage | T2-T3 | 26 | 5 | 16 | 5 | 11.150 | 0.004 |
T4 | 28 | 17 | 10 | 1 | |||
N stage | N0 | 11 | 2 | 8 | 1 | 3.686 | 0.158 |
N1-N3 | 43 | 20 | 18 | 5 | |||
TNM stage | I-II | 17 | 2 | 11 | 4 | 10.805 | 0.005 |
III-IV | 37 | 20 | 15 | 2 | |||
Nerve invasion | Yes | 29 | 17 | 10 | 2 | 8.696 | 0.013 |
N0 | 25 | 5 | 16 | 4 | |||
Vessel invasion | Yes | 29 | 15 | 12 | 2 | 3.514 | 0.173 |
No | 25 | 7 | 14 | 4 | |||
Histological grade | Low | 32 | 15 | 16 | 1 | 5.422 | 0.066 |
Middle-high | 22 | 7 | 10 | 5 | |||
Tumor size (cm) | <5 | 26 | 10 | 11 | 5 | 3.637 | 0.162 |
≥5 | 28 | 12 | 15 | 1 | |||
Tumor site | Cardiac | 13 | 6 | 7 | 0 | 3.537 | 0.171 |
Non-cardiac | 41 | 16 | 19 | 6 | |||
Tumor and normal | Tumor | 54 | 22 | 26 | 6 | 14.318 | 0.001 |
Normal | 54 | 14 | 23 | 17 | |||